All Ali Ellebedy articles
-
NewsStudy uncovers how mRNA vaccination may broaden flu antibody responses
A new study finds that mRNA vaccination sustained influenza-specific germinal-center activity for up to six months in some participants.
-
NewsResearchers find a common weakness in major gut pathogens
The bacteria enterotoxigenic E. coli and Shigella together cause hundreds of millions of infections each year and are among the leading causes of diarrheal death, especially in children. A shared biological feature of these gut pathogens could lead to a vaccine that protects against both.
-
NewsmRNA flu vaccine offers immune protection against wide array of influenza virus strains
A new study has found that an investigational mRNA influenza vaccine helps the immune system recognize a wider range of influenza viruses than today’s standard flu shot, offering stronger and potentially longer-lasting protection. The vaccine, developed by Moderna, is currently under review by the U.S. Food and Drug Administration.
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.